Largest study of CTE in male ice hockey players finds odds increased 34% with each year played

A large study, of 77 deceased male ice hockey players, has found that the odds of having chronic traumatic encephalopathy (CTE) increased by 34% each year played, and 18 of 19 National Hockey League players had CTE. CTE is a neurodegenerative disease caused by repeated traumatic brain injuries and most frequently found in former contact… Continue reading Largest study of CTE in male ice hockey players finds odds increased 34% with each year played

1352 Impact of timing of real-world CT imaging on cost-effectiveness of a molecular biomarker for treatment response monitoring of immunotherapy

Background Studies have demonstrated that dynamic molecular biomarkers for treatment response monitoring (TRM) of immune checkpoint inhibitors (ICI) can predict clinical outcomes. However, there is little data on when a molecular biomarker is best integrated into clinical practice based on timing of Computed Tomography (CT) imaging. Here, we characterize real-world (RW) imaging patterns in a… Continue reading 1352 Impact of timing of real-world CT imaging on cost-effectiveness of a molecular biomarker for treatment response monitoring of immunotherapy

1212 Utilization of artificial intelligence support for early lung cancer diagnosis in a lung nodule program: a retrospective cohort study

Background This study evaluates combined Artificial Intelligence (AI)-guided lung nodule identification, risk stratification, and tracking in a lung nodule program at a large academic medical center (AMC) as compared to current practice. The primary objective was to assess the number of clinically relevant lung nodules (8–30mm, and/or recommended for follow-up by radiology) that would be… Continue reading 1212 Utilization of artificial intelligence support for early lung cancer diagnosis in a lung nodule program: a retrospective cohort study

315 Improving pediatric neuroblastoma immunotherapy outcome by using B7-H3 CAR-T cells in combination with low-dose external beam radiation therapy (EBRT): preclinical development in murine models

Background High-risk neuroblastoma accounts for ~10% of childhood cancer deaths. Despite improvements in treatment, the 5-year overall survival remains only ~50%. CAR-T cell therapy has shown remarkable success in hematological tumors, including children with relapsed ALL. However, CAR-T cell therapy has shown limited response in high-risk neuroblastoma or other solid tumors due in part to… Continue reading 315 Improving pediatric neuroblastoma immunotherapy outcome by using B7-H3 CAR-T cells in combination with low-dose external beam radiation therapy (EBRT): preclinical development in murine models